SLN - Silence Therapeutics plc

QQQ $ 480.17 $ 0.57 (0.12 %)

DIA $ 389.57 $ -0.54 (-0.14 %)

SPY $ 544.41 $ 0.81 (0.15 %)

TLT $ 93.39 $ -0.17 (-0.18 %)

GLD $ 212.76 $ -1.43 (-0.67 %)

Previous Close

$ 19.95

Open

$ 19.23

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 19.23 - $ 19.23

52 Week Range

$ 4.84 - $ 27.72

Volume

90,094

Average Volume

Market Cap

2.37B

Beta (5Y Monthly)

$ 1.06

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Silence Therapeutics To Receive $2M Resear...
06/24/2024 12:35:16

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology...

The Analyst Landscape: 6 Takes On Silence ...
06/20/2024 16:00:38

HC Wainwright & Co. Reiterates Buy on Sile...
06/20/2024 15:32:59

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

Silence Therapeutics Announces Topline 48-...
06/20/2024 11:37:56

HC Wainwright & Co. Reiterates Buy on Sile...
05/31/2024 10:33:38

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

HC Wainwright & Co. Reiterates Buy on Sile...
05/24/2024 16:46:46

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

HC Wainwright & Co. Reiterates Buy on Sile...
05/17/2024 17:40:53

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

What 7 Analyst Ratings Have To Say About S...
05/17/2024 13:01:00

Chardan Capital Maintains Buy on Silence T...
05/17/2024 12:50:28

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $42 price target.

Silence Therapeutics Q1 Collaboration Reve...
05/16/2024 12:42:39

Beyond The Numbers: 7 Analysts Discuss Sil...
04/22/2024 18:00:53

Morgan Stanley Maintains Overweight on Sil...
04/22/2024 17:29:59

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and maintains $45 price tar...

Silence Therapeutics Announces JAMA Public...
04/08/2024 15:49:21

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology...

HC Wainwright & Co. Reiterates Buy on Sile...
03/15/2024 16:57:20

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

these-analysts-boost-their-forecasts-on-silence-therapeutics-after-full-year-2023-results

These Analysts Boost Their Forecasts On Si...
03/14/2024 18:01:29

Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday.

Morgan Stanley Maintains Overweight on Sil...
03/14/2024 16:33:40

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and raises the price target...

Chardan Capital Maintains Buy on Silence T...
03/14/2024 11:54:52

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and raises the price target from $...

What 4 Analyst Ratings Have To Say About S...
03/13/2024 20:01:18

HC Wainwright & Co. Maintains Buy on Silen...
03/13/2024 15:34:02

HC Wainwright & Co. analyst Patrick Trucchio maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 pr...

whats-going-on-with-silence-therapeutics-stock-today

What's Going On With Silence Therapeutics ...
03/13/2024 14:16:29

Silence Therapeutics reports narrower Q4 loss, data from zerlasiran study, and strengthened cash position. In March 2024, Malli...